News

Investigators presented information on the 9-month interim results of the ABX464-102 phase 2a examining efficacy in UC patients at DDW 2019.

Ranibizumab was approved for AMD treatment in Korea in 2007, but most supporting trials had been conducted among Caucasian patients.

FDA announced approval of Sorilux Foam, which had previous approval for adults, for adolescents between the ages of 12 and 17.

David Kingdon, MD, FRCPsych, professor of mental health care delivery at the University of Southampton, sat down with MD Magazine at APA 2019 to discuss recent advances in psychosis.

Investigators from Baylor College of Medicine found that dawn to sunset fasting may be a new treatment approach for obesity, metabolic syndrome and NAFLD.

Study from DDW 2019 found that rates of nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and nonalcoholic cirrhosis was more than double in patients with UC.

A study presented at APA 2019 found that esketamine spray to be an effective, fast-acting treatment for people with treatment-resistant depression.

A study presented at DDW 2019 found that endoscopic retrieval may help prevent further gastric damage from button battery ingestion.

In a study presented at Digestive Disease Week 2019, results indicated the risk of developing Parkinson's disease was 3 times higher in patients who had appendectomies.

A study presented at DDW 2019 found that women with intrahepatic cholestasis of pregnancy were 5.7 times more likely to have a NAFLD diagnosis

Study presented at DDW 2019 found that walking and resistance training was associated with a lower risk of cirrhosis-related death.

A study presented at DDW 2019 found that endoscopic sleeve gastroplasties found significant and sustainable weight loss among patients 5 years after surgery.

Study presented at DDW 2019 found that transplantation of gut microbes from lean donor could aid weight loss in obese, metabolically healthy recipients.

A review highlights aflibercept’s efficacy in treatment non-responders and points to a couple promising new AMD therapies in development.

The Submitted Biologics Application for AR101, the first potential pediatric food allergy preventive therapy, will be considered on September 13.

Teduglutide (Gattex) has been approved as an injection for pediatric patients 1 year of age and older with Short Bowel Syndrome.

New clinical findings go against the advisory of the GOLD 2017 classification.

Positive findings for the envelope support some of the first indications that a preventive measure could address cardiac surgery infection rates.

Children with asthma who used the eAsthma Tracker app weekly missed 60% fewer days of school and their parents missed 70% fewer days of work.

The novel Person-Centered Primary Care Measure has established 11 domains that each represent a single item representing the broad scope of primary care. The team behind it has created a measure that “actually aligns with the work of primary care physicians, and what matters to patients.”

Teens and adults had similar weight loss after gastric bypass surgery, but teens were more likely to experience remission of type 2 diabetes and hypertension than adults.

Dalteparin sodium injection was shown to result in VTE resolution in a majority of treated patients from a clinical trial.

Self-reported vision impairment was associated with a greater risk of developing depression and anxiety symptoms in patients 65 and older.

Metformin use associated with a 58% reduced risk of age-related macular degeneration (AMD) in a case-controlled retrospective study.

Patients on 2 different doses of the once-daily oral JAK1 inhibitor reached statistically significant measures for improved symptoms.

A recent study found that recreational cannabis legalization can lead to increase in car accidents and injuries, but decreases in chronic pain admissions.

Patients diagnosed with psoriasis face a nearly three-fold greater risk of developing anxiety disorders.

CompEx combines deteriorations and frequency of asthma exacerbations that are recorded twice daily by patients. An algorithm is developed based off of patient deterioration below threshold limits.